CE Celanese Corp Insider Trading

CE CEO Scott A Richardson purchased 3,800 shares at $41.59 on 2025-12-10 (Total value: $158,041.62). Stock currently at $43.50, -41.3% from 52-week high.

Richardson Scott A, as CEO & President, executed an open-market purchase of 3,800 shares at $41.59, increasing his holdings to 70,448 shares post-transaction. The purchase occurs in a difficult context: Celanese is trading 41.3% below its 52-week high and reported a negative net income of $-1,357,000,000.00 (loss of $1.4B) over its most recent full fiscal year, alongside negative annual revenue growth of -6.0%. While the insider's cross-ticker track record shows 4 prior sells with a 100.00% well-timed rate at the 90-day mark, his same-ticker history at CE consists of 4 prior sells (all in 2024), each well-timed with negative 90-day returns, suggesting he has a pattern of exiting ahead of declines. This buy reverses that pattern; whether it represents renewed conviction in a recovery or a routine portfolio adjustment cannot be determined from transaction data alone, but the company's ongoing losses and revenue contraction merit scrutiny.

CE CFO buys 5,000 shares at $41.03 amid -6.0% revenue decline and -$1.4B annual net loss.

Kyrish Chuck, SVP & CFO of Celanese Corp, acquired 5,000 shares at $41.03 on 2025-12-09, increasing his holdings by 84.5% from 5,914 to 10,914 shares. The purchase occurred while the company faces significant headwinds: annual revenue declined 6.0% to $2.4B, the company reported a net loss of -$1.4B over its most recent full fiscal year, and the stock is currently 42.3% below its 52-week high of $74.12. The timing of this insider acquisition by a senior finance executive during a period of operational and financial distress provides material context for investors monitoring the company's turnaround trajectory and management's assessment of intrinsic value.

Director Timothy Go bought 1,039 shares of Celanese (CE) for $48,053.33 on 2025-09-08, raising holdings 30.8%.

Director Timothy Go purchased 1,039 shares across 2 transactions on 2025-09-08 at a blended average price of $46.25, increasing his holdings from 3,376 to 4,415 shares (+30.8%). The purchase occurred as Celanese trades -68.0% from its 52-week high and -23.2% over the past 90 days, with fundamentals showing the company was unprofitable over its most recent full fiscal year and revenue declining 6.0% year-over-year. Go's cross-ticker track record shows 1 prior buy with an average 90-day return of -11.0% and a 0% win rate, providing limited evidence of prescient timing in his historical open-market purchases. The accumulation occurs amid financial headwinds and poor near-term price momentum, with the current price at $44.68 already below his execution prices.

Director Galante buys 2,400 CE shares at $41.27; 3 other insiders also bought within 14 days—cluster activity in stock down -69.2% from 52-week high.

Director Edward G. Galante purchased 2,400 shares of Celanese at $41.27 on 2025-08-14, bringing his holdings from 18,977 to 21,377 shares. This purchase occurs within a cluster of 3 other insider buys over the same 14-day period, suggesting coordinated appetite for accumulation at current levels. The company's fundamentals are pressured: it was unprofitable over its most recent full fiscal year, annual revenue declined -6.0%, and the stock has declined -24.8% over 30 days and -19.8% over 90 days, putting it -69.2% below its 52-week high of $139.82. The cluster buy pattern against a backdrop of deteriorating fundamentals and severe price weakness warrants investor attention to understand whether insiders view the decline as creating a durable entry point or whether the purchases reflect scheduled activity divorced from valuation assessment.

Director Moorthy Ganesh bought 1,000 shares of CE at $40.94 as part of cluster buying; stock down -69.2% from 52-week high.

Director Moorthy Ganesh purchased 1,000 shares at $40.94 on 2025-08-14, increasing his holdings by 19.9% to 6,015 shares. The purchase is noteworthy as part of a 3-insider cluster buy within the past 14 days, suggesting coordinated board-level activity during a period of significant stock weakness. Celanese is trading at $43.11, down -69.2% from its 52-week high of $139.82 and -24.8% over the past 30 days, while the company faced negative full-year net income despite $2.5B in quarterly revenue and -6.0% annual revenue growth. Ganesh's prior two CE purchases (2025-03-12 and 2025-03-07) showed mixed 90-day timing (1 of 2 well-timed), warranting scrutiny of whether this cluster activity reflects genuine fundamental conviction or opportunistic accumulation during distressed valuation conditions.

Director Sutton Scott McDougald buys 2.0K shares of CE at $40.89; stock down 69.2% from 52-week high, -24.8% in 30 days. Cluster pattern: 3 other insiders also bought within 14 days.

McDougald, a director of Celanese Corp, purchased 2,000 shares at $40.89 on 2025-08-14, increasing holdings by 10.9% to 20,376 shares total. The stock has fallen sharply: -69.2% from its 52-week high of $139.82 and -24.8% over the past 30 days, trading at $43.11 currently. His prior buy at CE in March 2025 saw a 90-day return of -0.2%, indicating poor timing; his cross-ticker record shows 0 of 1 prior buys were well-timed at the 90-day mark. Notably, this transaction is part of a cluster: 3 other insiders have also bought CE within the past 14 days. The company's fundamentals are weak—annual revenue declined 6.0%, it was unprofitable over its most recent full fiscal year, and the current quarter generated only $199.0M in net income against $2.5B in revenue. The convergence of a director's discretionary purchase amid sharp price declines, combined with simultaneous buying by three other insiders during a period of negative earnings and revenue contraction, suggests a coordinated response to depressed valuations rather than confidence driven by business performance.

SVP Murray Mark Christopher bought 2,017 shares of Celanese at $41.83 on 2025-08-14; stock down 69.2% from 52-week high; 3 other insiders also bought within 14 days.

Murray Mark Christopher, SVP – Acetyls, purchased 2,017 shares at $41.83 on 2025-08-14, increasing his holdings from 14,983 to 17,000 shares (+13.5%). The buy occurred as Celanese stock trades -69.2% from its 52-week high of $139.82 and -24.8% over the past 30 days, reflecting significant downward price pressure. Christopher's prior trades at Celanese show mixed timing: of 3 measurable 90-day outcomes at this ticker, 2 resulted in positive 90-day returns (+2.6%, +24.8%), though his most recent prior buy on 2025-03-07 delivered only +0.1% over 90 days despite an initial 30-day decline of -24.7%. A cluster pattern is present: 3 other insiders purchased within the past 14 days, suggesting coordinated assessment of value at depressed price levels. However, company fundamentals show contraction (revenue down 6.0% annually) and recent unprofitability, warranting caution about the strength of the buying signal.

SVP Murray Mark Christopher buys 1,479 shares of Celanese (CE) at $52.18, raising stake to 15,468 shares amid stock rebound from 52-week lows.

SVP Murray Mark Christopher purchased 1,479 shares at $52.18, increasing his holdings by 10.6% to 15,468 shares. The stock is currently trading at $53.93, up 23.1% over 30 days and up 6.7% over 90 days, yet remains 64.7% below its 52-week high of $152.87. In his prior two measurable same-ticker purchases, one buy (2024-03-08) returned +4.0% at 30 days while underperforming at 90 days (-5.9%), and a 2023 buy was more successful (+11.7% and +24.8%). His cross-ticker track record shows mixed timing, with an average 90-day return of +9.5% across 3 prior buys and a 50% win rate. The company faces headwinds: it is unprofitable (net income of $-21.0M in the latest quarter) with annual revenue declining 6.0%, though this purchase coincides with recent price appreciation rather than an absolute bottom.

Director Moorthy Ganesh buys 1,000 shares of CE at $53.29; stock down -69.1% from 52-week high; cluster of 3 other insider buys within 14 days.

Moorthy Ganesh, a director of Celanese Corp, purchased 1,000 shares at $53.29 on 2025-03-12, increasing his holdings to 3,000 shares—a 50.0% increase from his prior 2,000 shares. The transaction occurred against a backdrop of significant price deterioration: the stock trades at $53.09, down -69.1% from its 52-week high of $171.86, and has declined -20.5% over the past 30 days and -22.6% over 90 days. Notably, this purchase is part of a cluster pattern, with 3 other insiders also buying within the past 14 days, suggesting coordinated accumulation at depressed price levels. However, the company reported annual revenue decline of -6.0%, full-year unprofitability, and a quarterly net income of $116.0M against $2.6B revenue, indicating operational stress that may be driving the stock's weakness rather than merely a valuation opportunity.

Director Deborah J. Kissire bought 1,000 shares of Celanese at $54.28; cluster pattern as 3 other insiders also bought within 14 days.

Kissire, a director, purchased 1,000 shares at $54.28 on 2025-03-07, expanding her holdings by 82.4% from 1,214 to 2,214 shares. The stock is trading at $54.22 (current price), representing a 68.4% decline from its 52-week high of $171.86 and down 20.3% over the past 30 days. Critically, this purchase occurs within a 14-day window in which 3 other insiders also bought shares, constituting a cluster buy pattern. While Kissire's prior open-market buy activity across all tickers shows a 100% 90-day win rate averaging 24.3% return, the company's fundamentals remain challenged: annual revenue declined 6.0% year-over-year, and the firm posted negative full-year net income despite $116.0M in latest-quarter earnings. The confluence of multiple insider purchases amid a depressed stock price warrants attention to whether management views current valuations as attractive.